Hisano Marcelo, Bruschini Homero, Nicodemo Antonio Carlos, Gomes Cristiano Mendes, Lucon Marcos, Srougi Miguel
Division of Urology, Hospital das Clínicas, University of São Paulo, Brazil.
Division of Urology, Hospital das Clínicas, University of São Paulo, Brazil.
Urology. 2015 Sep;86(3):492-7. doi: 10.1016/j.urology.2015.05.033. Epub 2015 Jul 8.
To analyze and compare the etiological uropathogens and the susceptibility profile findings on urine culture between sporadic cases of community-acquired, uncomplicated urinary tract infection (UTI) and recurrent UTI cases in women.
We retrospectively analyzed the clinical data of 1629 women with uncomplicated UTI evaluated at our hospital between January 2007 and December 2012. Patients were divided into 2 groups: (1) no recurrent UTI and (2) recurrent UTI. We analyzed the microbiological findings and compared susceptibility profiles between groups.
A total of 420 women were included. Group 1 had 233 (55.5%) patients and group 2 had 187 (44.5%). Escherichia coli was the most common agent in both groups (76.4% and 74.3%, respectively; P = .625), whereas Staphylococcus saprophyticus (8.2%) was the second most common in group 1, and Enterococcus faecalis was the second most common in group 2 (8.0%). Nitrofurantoin was the only oral agent that maintained the susceptibility profile in both groups (87.1% and 88.7%, respectively; P = .883). For E coli infections, only nitrofurantoin and amoxicillin/clavulanate maintained susceptibility rates more than 90% in both groups.
UTI episodes in patients with recurrent UTI had similar bacterial spectra, but different susceptibility profiles compared with those from patients with nonrecurrent infections. The susceptibility rate for nitrofurantoin in patients with recurrent UTI remained high and comparable to the observed in patients with sporadic UTI, reinforcing its indication for empirical treatment while waiting for urine culture results.
分析并比较社区获得性单纯性尿路感染(UTI)散发病例与复发性UTI女性患者尿培养的病原性尿路病原体及药敏结果。
我们回顾性分析了2007年1月至2012年12月间在我院评估的1629例单纯性UTI女性患者的临床资料。患者分为两组:(1)无复发性UTI组;(2)复发性UTI组。我们分析了微生物学结果并比较了两组间的药敏情况。
共纳入420例女性患者。第1组有233例(55.5%)患者,第2组有187例(44.5%)。大肠埃希菌是两组中最常见的病原体(分别为76.4%和74.3%;P = 0.625),而腐生葡萄球菌在第1组中是第二常见的(8.2%),粪肠球菌在第2组中是第二常见的(8.0%)。呋喃妥因是两组中唯一药敏情况保持稳定的口服药物(分别为87.1%和88.7%;P = 0.883)。对于大肠埃希菌感染,只有呋喃妥因和阿莫西林/克拉维酸在两组中的药敏率均保持在90%以上。
复发性UTI患者的UTI发作具有相似的细菌谱,但与非复发性感染患者相比药敏情况不同。复发性UTI患者中呋喃妥因的药敏率仍然很高,与散发性UTI患者中观察到的情况相当,这进一步证明了在等待尿培养结果期间将其作为经验性治疗药物的合理性。